Clinical Trial Update: Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013) [Phase 1]

View source ↗

Summary

Phase 1 study assessing how hepatic insufficiency affects pharmacokinetics of Grazoprevir (MK-5172-013) in Hepatitis C patients; completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Grazoprevir (grazoprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2016-03-04